Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle
MWN-AI** Summary
Retractable Technologies, Inc. (NYSE American: RVP) has recently been awarded an Innovative Technology designation from Vizient, a leading healthcare performance improvement company, for its EasyPoint® Blood Collection Tube Holder with Needle. This accolade signifies a recognition of the device's potential to enhance clinical care and safety for both patients and healthcare providers.
The EasyPoint Blood Collection Tube Holder employs automated retraction, allowing for in-vein activation that minimizes exposure to contaminated needles and significantly lowers the risk of needlestick injuries. Designed for ease of use, the device comes ready to operate with a pre-attached needle, removing the complexities of assembly and improving workflow efficiency. Its integrated low-profile safety mechanism also facilitates a clear view of the venipuncture site, which promotes higher success rates on the first attempt.
Key features include an off-line retraction mechanism that can be executed with one hand, providing a comfortable experience without necessitating any downward motion. Once activated, the needle is completely covered and rendered non-reusable, adhering to safety regulations and preventing further exposure.
Thomas Shaw, CEO of Retractable Technologies, expressed pride in receiving the designation, affirming the company's commitment to innovation and safety within healthcare settings. Kelly Flaharty from Vizient echoed this sentiment, highlighting the EasyPoint device's ability to significantly impact the healthcare industry.
Retractable Technologies is known for manufacturing safety medical products, including its renowned VanishPoint® brand, aimed at preventing needlestick injuries through designs that retract needles immediately after use. The company’s recognition by Vizient underscores the importance of continuous innovation in improving healthcare practices. For more details, visit www.retractable.com.
MWN-AI** Analysis
Retractable Technologies, Inc. (NYSE American: RVP) has garnered considerable attention after its EasyPoint® Blood Collection Tube Holder with Needle received the Innovative Technology designation from Vizient. This recognition from Vizient, a leader in healthcare performance improvement, underscores the product's potential to enhance safety, efficiency, and overall patient care within healthcare environments.
From a market perspective, this designation can significantly elevate Retractable’s profile among healthcare providers and investors. The recognition signals that the EasyPoint device is not just an innovation but a solution that addresses critical issues such as needlestick injuries and operational inefficiencies – factors that are paramount in today’s healthcare sector. As the healthcare market increasingly prioritizes safety and efficiency, products like the EasyPoint BCTH that minimize these risks are likely to gain traction, translating to growing sales for Retractable.
The product’s design streamlines workflow by eliminating the need for assembly, an advantage that resonates well with healthcare facilities looking to enhance operational efficiency. Furthermore, the safety features, especially the automated needle retraction, position Retraction Technologies on the leading edge of market demands, catering to an industry that is consistently seeking effective safety solutions.
However, potential investors should remain cautious. While the Innovative Technology designation represents a significant opportunity, it does not eliminate market risks such as competition from larger firms, fluctuations in demand, and dependence on healthcare spending cycles. Additionally, Retractable must navigate the complexities of regulatory compliance and patent protection.
In conclusion, for investors considering Retractable Technologies, the Innovative Technology designation presents a potentially lucrative opportunity, albeit within a framework of careful risk assessment. Monitoring product adoption rates and broader market trends will be vital in informing future investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Retractable Technologies, Inc. (NYSE American: RVP) announces its EasyPoint® Blood Collection Tube Holder with Needle has received an Innovative Technology designation from Vizient ® , the largest healthcare performance improvement company in the country.
Each year, healthcare experts serving on one of Vizient’s client-led councils review select products and technologies for their potential to enhance clinical care, patient safety, healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers the impact of these innovations on patient care and business models of healthcare organizations.
RTI’s innovative EasyPoint Blood Collection Tube Holder (BCTH) with Needle uses automated retraction to provide instant safety by allowing for in-vein activation, proven to effectively reduce exposure to the contaminated needle and reduce the risk of needlestick injuries. The EasyPoint BCTH with Needle is safe and easy to use right out of the package. The pre-attached needle eliminates the need for assembly prior to use, improving efficiency in preparation time and workflow, as well as streamlining inventory. The integrated, low-profile safety mechanism provides an optimal view of the venipuncture site, promoting first-attempt success. The attached thin-wall needle is triple-beveled and lubricated for patient comfort. The unique, off-line retraction is achieved using one hand without significant change in technique or grip, and does not require any downward motion, reducing the risk of patient discomfort. Upon retraction, the entire needle (front and back end) is completely covered and inaccessible, compared to back-end needles that remain exposed and accessible via the open end of many other tube holders. Once activated, the product is rendered non-reusable and prevents needle removal, in compliance with safety regulations.
“We are deeply honored that the EasyPoint Blood Collection Tube Holder with Needle has received a Vizient Innovative Technology designation,” said Thomas Shaw, CEO of Retractable Technologies, Inc. “This recognition affirms our ongoing commitment to developing solutions that provide safety, efficiency, and reliability in healthcare settings. From the very beginning, our mission has been to protect both patients and clinicians through engineering excellence and innovation, and the EasyPoint device reflects that mission in action. We are proud to see our team’s dedication acknowledged by one of the industry’s most respected organizations.”
“Congratulations to Retractable Technologies, Inc. for achieving this peer-designated status,” said Kelly Flaharty, associate vice president, contract operations, Vizient. “Our client council deemed the EasyPoint Blood Collection Tube Holder with Needle worthy of this designation for its potential to make a real difference in the healthcare industry.”
RETRACTABLE
Retractable manufactures and markets VanishPoint ® , EasyPoint®, and Patient Safe ® safety medical products. VanishPoint ® syringes, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe ® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. EasyPoint ® retractable needles can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint ® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.
For more information on Retractable, visit its website at www.retractable.com .
Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements.
Factors that could cause or contribute to such differences include, but are not limited to: material changes in demand; tariffs; Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251114641873/en/
Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President, Chief Financial Officer, and Chief Accounting Officer
FAQ**
How does the Vizient Innovative Technology designation impact the market reach and sales potential for Retractable Technologies Inc. (RVP) products, particularly the EasyPoint Blood Collection Tube Holder with Needle?
What strategies does Retractable Technologies Inc. (RVP) plan to implement to capitalize on the recognition from Vizient and enhance clinical care and patient safety through its innovative products?
With the EasyPoint BCTH with Needle improving workflow efficiency, how does Retractable Technologies Inc. (RVP) plan to continue innovating to address healthcare organizations' evolving needs and challenges?
Given the potential for increased demand, how is Retractable Technologies Inc. (RVP) preparing to manage production capacity and supply chain relationships in light of the innovative designation from Vizient?
**MWN-AI FAQ is based on asking OpenAI questions about Retractable Technologies Inc. (NYSE: RVP).
NASDAQ: RVP
RVP Trading
-2.8% G/L:
$0.6605 Last:
136,373 Volume:
$0.67 Open:
